NAD+ IV Therapy: What the Research Actually Says

NAD+ (nicotinamide adenine dinucleotide) has become the prestige offering of the IV therapy industry. Sessions are expensive (often $350 to $999 per infusion), they take two to four hours, and providers make strong claims about anti-aging, cognitive enhancement, and addiction recovery. Here is an honest look at what NAD+ actually is, what the research supports, and how to approach it with appropriate expectations.

What NAD+ Is and Why It Matters

NAD+ is a coenzyme found in every living cell. It participates in two fundamental categories of biological processes:

1. Energy metabolism: NAD+ is essential for converting food into cellular energy (ATP) through glycolysis, the citric acid cycle, and oxidative phosphorylation. Without it, your cells cannot produce energy.
2. Sirtuin activation and DNA repair: A class of proteins called sirtuins uses NAD+ as a substrate to regulate gene expression, DNA repair, and cellular stress responses. Sirtuins are associated with longevity in multiple model organisms.

NAD+ levels in human tissue decline steadily with age, roughly 50% between young adulthood and middle age in some tissue types. This decline has been associated with impaired energy metabolism, reduced DNA repair efficiency, and the accumulation of cellular damage that characterizes aging. This observation is the foundation of the NAD+ longevity hypothesis.

The Research Base: What We Know and What We Do Not

The research on NAD+ supplementation is genuinely promising, but it is also frequently overstated by providers. A clear-eyed look at the evidence:

What the Research Supports

• NAD+ levels decline with age: This is well-established in both animal and human tissue studies. The decline is real and correlates with multiple markers of metabolic health.
• Restoring NAD+ levels in aged animals produces meaningful effects: Multiple peer-reviewed studies in mice and other model organisms show that restoring NAD+ levels reverses age-associated decline in muscle function, metabolic rate, and even some aspects of cognitive performance. These are legitimate scientific findings.
• IV delivery raises blood NAD+ levels: IV NAD+ does reach the bloodstream and elevate circulating levels. This has been documented in clinical research.
• Addiction recovery context: Naturopathic and addiction medicine practitioners have used high-dose IV NAD+ in withdrawal management for decades. Some research supports its role in reducing cravings and withdrawal severity, though controlled clinical trials remain limited.

What the Research Does Not Yet Support

• Human longevity data: We do not have clinical trial data showing that NAD+ supplementation extends human lifespan or meaningfully slows aging in humans. The animal data is promising but does not translate directly.
• Cognitive enhancement in healthy adults: While NAD+ supports neurological function, evidence for meaningful cognitive improvement in healthy (non-deficient) adults from IV NAD+ is limited.
• Specific disease treatment: NAD+ IV therapy is not FDA-approved to treat any disease. Claims that it "treats" neurodegenerative conditions, cancer, or specific psychiatric diagnoses are not supported by current evidence.

What a NAD+ Session Actually Involves

NAD+ infusions are unlike standard wellness IVs in several practical ways:

• Duration: A typical session runs two to four hours, not 30-45 minutes. The compound must be administered slowly to prevent side effects. Some high-dose protocols take longer.
• Side effects during infusion: Many patients experience nausea, chest tightness, muscle aches, and a general sense of pressure or discomfort during the infusion, particularly if the drip rate is too fast. These sensations are not dangerous but are uncomfortable. They resolve by slowing the infusion or pausing briefly. Experienced providers anticipate this and titrate the rate accordingly.
• Post-infusion experience: Many patients report increased mental clarity, improved mood, and elevated energy within 24 to 48 hours after an infusion. The mechanism is plausible: cellular energy production may genuinely improve with elevated NAD+ levels. These subjective reports are consistent across a wide range of patients.
• Dosing: Common doses in wellness settings range from 250mg to 1000mg. Smaller doses (125 to 250mg) are used for standard wellness protocols. Larger doses (500 to 1000mg) are more common in intensive or addiction recovery protocols. Higher doses correlate with more pronounced side effects during infusion.

NAD+ vs. NAD+ Precursors: A Critical Distinction

The supplement market sells two NAD+ precursors: nicotinamide riboside (NR, marketed as Tru Niagen and similar products) and nicotinamide mononucleotide (NMN). These oral supplements raise NAD+ levels through the salvage pathway, a biochemical route that converts these precursors back into NAD+.

IV NAD+ bypasses this conversion entirely, delivering the coenzyme directly. This produces higher and faster peak blood levels than oral precursors. Whether higher peak levels produce meaningfully different outcomes than the sustained, moderate elevation from oral precursors is not definitively established. For someone seeking NAD+ support on an ongoing basis, oral NR or NMN supplements may provide a cost-effective complement to periodic IV infusions rather than replacing them entirely.

The Cost Question

NAD+ IV therapy is expensive by design. The compound itself costs significantly more per gram than standard vitamins and minerals. The sessions are long, requiring a clinical professional for two to four hours. And the protocols typically involve a series of sessions rather than a single visit.

Typical cost structure:

• Single 250mg session: $350 to $499
• Single 500mg session: $500 to $750
• Single 1000mg session: $750 to $1,000
• Initial series (3 to 5 sessions): $1,200 to $3,500 depending on dose and market

Evaluate whether the potential benefit aligns with this cost given your specific goals. For healthy adults seeking general wellness, the cost-benefit ratio looks different than for someone using it as part of an addiction recovery protocol under physician supervision, where the evidence base is stronger.

Who Is Most Likely to Benefit

The strongest candidates for NAD+ IV therapy are:

• Adults over 40 who notice declining energy and cognitive sharpness that may relate to age-associated NAD+ decline
• People in addiction recovery using it as part of a medically supervised withdrawal and recovery protocol
• People with specific conditions associated with mitochondrial dysfunction, under the guidance of a physician who understands the research

Healthy adults in their 20s or early 30s seeking cognitive enhancement are working with less evidence and paying a significant premium for largely speculative benefit relative to other interventions. The honest answer is that more research is needed before categorical claims can be made for any specific population.

Finding a Quality NAD+ Provider

NAD+ administration requires more clinical oversight than a basic hydration drip. Look for providers who:

• Discuss your health history specifically before recommending a dose
• Explain the expected side effects during infusion and how they manage them
• Source their NAD+ from an FDA-registered 503B compounding pharmacy
• Have a physician medical director who is actually involved in clinical oversight, not just listed on a website
• Do not promise specific medical outcomes or make disease claims

NAD+ is a legitimate area of scientific inquiry with real biological rationale. It is also an area where provider claims often significantly outpace the current evidence. Approach it with realistic expectations and find a provider who will discuss it honestly.